Cytek Biosciences Inc
NASDAQ:CTKB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
|
M&G PLC
OTC:MGPFY
|
UK |
|
CAE Inc
TSX:CAE
|
CA |
|
N
|
Northern Trust Corp
DUS:NT4
|
US |
|
Westpac Banking Corp
ASX:WBC
|
AU |
|
A
|
Absa Group Ltd
JSE:ABG
|
ZA |
|
K
|
Kawasaki Heavy Industries Ltd
DUS:KHE
|
JP |
|
B
|
Beyond Securities PCL
SET:BYD
|
TH |
|
Volta Metals Ltd
OTC:VOLMF
|
CA |
Wall St Price Targets
CTKB Price Targets Summary
Cytek Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CTKB is 5.99 USD with a low forecast of 5.05 USD and a high forecast of 7.88 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CTKB's stock price target?
Price Target
5.99
USD
According to Wall Street analysts, the average 1-year price target for
CTKB is 5.99 USD with a low forecast of 5.05 USD and a high forecast of 7.88 USD.
What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
8%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.